Закупка лекарственных препаратов МНН: Молсидомин, Телмисартан

This state procurement tender from Russia concerns the acquisition of specific pharmaceutical drugs identified by their International Nonproprietary Names (INN): Molsidomine and Telmisartan. The contracting authority, likely a hospital, clinic, or pharmacy, requires these medications for patient treatment. Molsidomine is used to treat angina, while Telmisartan is an angiotensin II receptor blocker used to treat hypertension and other cardiovascular conditions. The tender will specify the required dosages, forms (e.g., tablets, capsules), strengths, quantities, and packaging. Bidders must be licensed pharmaceutical distributors or manufacturers capable of supplying high-quality, registered medications. Key requirements include strict adherence to pharmaceutical regulations, Good Distribution Practices (GDP), and ensuring the authenticity and efficacy of the drugs. Compliance with Russian pharmaceutical standards and providing necessary documentation, such as registration certificates and quality control data, will be essential for bidders.